Canada’s drug prices are the fourth highest in the developed world. New guidelines aimed at lowering prescription drug prices have been in process for more than 2 years, and have met with intense pressure by the industry lobby group, Innovative Medicines Canada. Dr. Joel Lexchin examines the lies and half-truths put out by IMC. Lexchin is Professor Emeritus of Health Policy and Management at York University.